Cencora ($COR) updates segment reporting effective FY2026 Q1 (period ended Dec 31, 2025).
Filed with the SEC on · Summarized by InvestorsBot
Cencora ($COR) updates segment reporting effective FY2026 Q1 (period ended Dec 31, 2025). New structure: U.S. Healthcare Solutions; International Healthcare Solutions; Other (non‑reportable). 8‑K filed Feb 10, 2026 to revise 2025 10‑K items. 📊 #Cencora #SECfiling
Segment makeup: U.S. Healthcare = U.S. Human Health (excl. legacy U.S. Consulting). International = Alliance Healthcare, Innomar, World Courier, strategic Pharmalex. Other = MWI Animal Health, Profarma, U.S. Consulting Services, remaining Pharmalex. 🌍 $COR #Healthcare
Key investor note: revisions reclassify segment results in 2025 10‑K (Exhibit 99.1) but do NOT restate audited consolidated financials. For subsequent developments see 2026 Q1 Form 10‑Q (filed Feb 4, 2026). 🔎 $COR #SECfiling #Investing